Publications by authors named "Norifumi Nishide"
Article Synopsis
- - The study examined the effectiveness of S-1 and modified FOLFIRINOX (mFFX) as second-line treatments for unresectable pancreatic cancer (UPC) after patients failed gemcitabine plus nab-paclitaxel (GnP) therapy, noting that results for these options have limited documentation.
- - Out of 86 UPC patients, 41 received S-1 and 21 received mFFX, with mFFX generally prescribed to younger patients in better health; both treatments showed similar average progression-free and overall survival durations.
- - While S-1 had a lower rate of severe side effects (20%) compared to mFFX (57%), the latter led to a higher response rate
Definitive chemoradiotherapy(CRT)for esophageal cancer is the standard treatment and alternative to surgery. However, the tolerability of CRT in elderly patients is not well known. In this study, we retrospectively analyzed 60 patients with esophageal cancer who were treated with CRT(5-FU 700 mg/m2, cisplatin 70 mg/m2, radiation 60 Gy)at our hospital between January 2015 and September 2017.
View Article and Find Full Text PDF